Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

There is no link between hair loss and prostate enlargement.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

Large prostate patients more likely to have hair loss.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Finasteride improves prostate cancer detection in PSA test.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

Microneedles are effective for drug delivery, vaccinations, fluid extraction, and treating hair loss, with advancements in manufacturing like 3D printing.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Eruptive vellus hair cysts are rare, benign skin lesions that are hard to treat.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Finasteride can cause a unique skin reaction on the penile shaft.

Women with congenital adrenal hyperplasia showed no prostatic growth.

ILC1 cells contribute to hair loss in alopecia areata.